Marion van Mackelenbergh

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy

Carsten Denkert, Gϋnter von Minckwitz, Silvia Darb‐Esfahani et al. · The Lancet Oncology · 2017 · 2K citations

Breast Oncology, Neoadjuvant Therapy, Medicine +9

Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

Thomas Karn, Carsten Denkert, Karsten E. Weber et al. · Annals of Oncology · 2020 · 233 citations

Early Tnbc, Tumor Mutational Burden, Cancer Immunosurveillance +9

Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial

Ines Stevic, Volkmar Müller, Karsten E. Weber et al. · BMC Medicine · 2018 · 201 citations · Full text

Large scale multifactorial likelihood quantitative analysis of <i>BRCA1</i> and <i>BRCA2</i> variants: An ENIGMA resource to support clinical variant classification

Michael T. Parsons, Emma Tudini, Hongyan Li et al. · Human Mutation · 2019 · 148 citations · Full text

Genetics, Genetic Epidemiology, Pathology +25

Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial

Alba Llop‐Guevara, Sibylle Loibl, Guillermo Villacampa et al. · Annals of Oncology · 2021 · 97 citations

Homologous Recombination Deficiency, Breast Oncology, Medicine +8